Advertisement

Nasopharyngeal Carcinoma

  • G. de-Thé

Abstract

The geographic distribution of the main types of human cancers is such that variations up to 100- and even 1000-fold exist for the incidence of specific tumors, suggesting that environmental factors play a critical role in their development. (54) Furthermore, if chemicals are generally believed to play the major role, microbiological agents should not be overlooked. Because carcinogenesis is accepted by most epidemiologists to represent a multistep and multifactorial process, (37,172) both chemical and biological carcinogens mays interact in such a process.

Keywords

Nasopharyngeal Carcinoma Infectious Mononucleosis Nasopharyngeal Cancer Salted Fish Pharyngeal Carcinoma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Ali, M. Y., And Shanmugaratnam, K., Cytodiagnosis of nasopharyngeal carcinoma, Acta Cytol. 11: 51–60 (1967).Google Scholar
  2. 2.
    Anderson, E. N., JR., Anderson, M. L., And Ho, J. H. C., A study of the environmental backgrounds of young Chinese nasopharyngeal carcinoma patients, in: Nasopharyngeal Carcinoma: Etiology and Control (G. DE-Tut And Y. ITo, Eds.), pp. 231–239, Iarc Scientific Publication No. 20, Iarc, Lyon, France, 1978.Google Scholar
  3. 3.
    Andersson-Anvret, M., Forsby, N., Klein, G., And Henle, W., Studies on the occurrence of Epstein-Barr virus Dna in nasopharyngeal carcinomas in comparison with tumors of other head and neck regions, Int. J. Cancer 20: 702–707 (1977).CrossRefGoogle Scholar
  4. 4.
    Andersson-Anvret, M., Forsby, N., Klein, G., And Henle, W., The association between undifferentiated nasopharyngeal carcinoma and Epstein-Barr virus shown by correlated nucleic acid hybridization and histopathological studies, in: Nasopharyngeal Carcinoma: Etiology and Control (G. DE-Tut. And Y. ITo, Ens.), pp. 347–358, Iarc Scientific Publication No. 20, Iarc, Lyon, France, 1978.Google Scholar
  5. 5.
    Andrews, R. A. I., And Michaels, L., Nasopharyngeal carcinoma in Canadian bush pilots, and aviator’s cancer, Lancet 2: 85, 640 (1968).PubMedCrossRefGoogle Scholar
  6. 6.
    Armstrong, R. W., Armstrong, M. J. Yu, M. C., And Henderson, B. E., Salted fish and inhalants as risk factors for nasopharyngeal carcinoma in Malaysian Chinese, Cancer Res. 43: 2967–2970 (1983).PubMedGoogle Scholar
  7. 7.
    Armstrong, R. W., Kannan-Kutty, M., And Armstrong, M. J., Self-specific environments associated with nasopharyngeal carcinoma in Selangor, Malaysia, Soc. Sci. Med. 12: 149–156 (1978).PubMedCrossRefGoogle Scholar
  8. 8.
    Atlas of Cancer mortality in the People’s Republic of China, edited by the editorial Committee for the Atlas of Cancer mortality in the People’s Republic of China, China Map Press, Beijing, 1979.Google Scholar
  9. 9.
    Aya, T., And Osato, T., Early events in transformation of human cord leukocytes by Epstein-Barr virus: Induction of Dna synthesis, mitosis and the virus associated nuclear antigen synthesis, Int. J. Cancer 14: 341–347 (1974).PubMedCrossRefGoogle Scholar
  10. 10.
    Bailar, J. C., Iii, Race, environment and family in the epidemiology of cancer of the nasopharynx, in: Cancer of the Nasopharynx, Vol. I (C. S. Muir And K. Shanmugaratnam, Eds.), pp. 101–105, Uicc Monograph Series, Munksgaard, Copenhagen, 1967.Google Scholar
  11. 11.
    Benyesh-Melnick, M., Fernbarch, D. J., And Lewis, R. T., Studies on human leukemia. I. Spontaneous lymphoblastoid transformation of fibroblastic bone marrow cultures derived from leukemic and non-leukemic children, J. Natl. Cancer Inst. 31: 1311–1331 (1963):Google Scholar
  12. 12.
    Betuel, H., Cammoun, M., CoLombani, J., Day, N. E., Ellouz, R., And de-Thé, G., The relationship between nasopharyngeal carcinoma and the HL-A system among Tunisian, Int. J. Cancer 16: 249–254 (1975).PubMedCrossRefGoogle Scholar
  13. 13.
    Bjarnason, O., Day, N., Snaedal, G., And Tulinius, H., The effect of year on the breast cancer age incidence curve in Iceland, Int. J. Cancer 13: 689–696 (1974).PubMedCrossRefGoogle Scholar
  14. 14.
    Blot, W. J., Lanier, A., And Farumeni, J. F., JR., Cancer mortality among Alaskan natives 1960–1969, J. Natl. Cancer Inst. 55: 547–554 (1975).PubMedGoogle Scholar
  15. 15.
    Brooks, L., Yao, P. Y., Rickinson, A. B., And Young, L. S., Epstein-Barr virus latent gene transcription in nasopharyngeal carcinoma cells: Co-expression of Ebna-1, Lmp.1, and Lmp.2 transcripts, J. Virol. 66: 2689–2697 (1992).PubMedGoogle Scholar
  16. 16.
    Brousset, P., Butet, V., Chittal, S., Selves, J., And Delsol, G., Comparison of in situ hybridization using different non- isotopic probes for detection of Epstein-Barr virus in nasophar- yngeal carcinoma and immunohistochemical correlation with anti- latent membrane protein antibody, Lab. Invest. 67: 457–464 (1992).PubMedGoogle Scholar
  17. 17.
    Buell, P., Nasopharyngeal cancer in Chinese of California, Br. J. Cancer 19: 459–470 (1965).PubMedCrossRefGoogle Scholar
  18. 18.
    Buell, P., Race and place in the etiology of nasopharyngeal cancer: A study based on California death certificates, Int. J. Cancer 11: 268–272 (1973).PubMedCrossRefGoogle Scholar
  19. 19.
    Bukturr, D. P., The trail to a virus, in: Oncogenesis and Herpes-viruses (P. M. Biggs, G. DE-THÉ, And L. N. Payne, Eds.), pp. 345–348, Iarc Scientific Publication No. 2, Iarc, Lyon, France, 1972.Google Scholar
  20. 20.
    Cammoun, M., Vogt-Hoerner, G., And Mourali, N., Les tumeurs du naso-pharynx en Tunisie: Etude anatomo-clinique de 143 observations, Tunis Med. 49 (3): 131–141 (1971).Google Scholar
  21. 21.
    Chan, S. H., Chew, T. S., Goh, E. H., Simons, M. J., And Shanmugaratnam, K., Impaired general cell-mediated immune functions in vivo and in vitro in patients with nasopharyngeal carcinoma, Int. J. Cancer 18 (2): 139–144 (1976).PubMedCrossRefGoogle Scholar
  22. 22.
    Churchill, A. E., Payne, L. N., And Chubb, R. C., Immunization against Marek’s disease using a live attenuated virus, Nature 221: 744–747 (1969).PubMedCrossRefGoogle Scholar
  23. 23.
    Clifford, P., Carcinoma of the nasopharynx in Kenya, East Afr. Med. J. 42: 373–396 (1965).PubMedGoogle Scholar
  24. 24.
    Clifford, P., Malignant diseases of the nasopharynx and para-nasal sinuses in Kenya, in: Cancer of the Nasopharynx (C. S. Muir And K. Shanmugaratnam, Eds.), pp. 82–94, Uicc Monograph Series, Vol. 1, Munksgaard, Copenhagen, 1967.Google Scholar
  25. 25.
    Clifford, P., A. Review on the epidemiology of nasopharyngeal carcinoma, Int. J. Cancer 5: 287–309 (1970).PubMedCrossRefGoogle Scholar
  26. 26.
    Clifford, P., Carcinogens in the nose and throat: Nasopharyngeal carcinoma in Kenya, Proc. R. Soc. Med. 65: 682–686 (1972).PubMedGoogle Scholar
  27. 27.
    Derry, D. E., Anatomical report (B), in: Archaeological Survey of Nubia (Bulletin No. 3), pp. 40–42, Egyptian Ministry of Finance, Cairo, 1909.Google Scholar
  28. 28.
    Deschryver, A., FRmErg, S., JR., Klein, G., Henle, W., Henle, G., DE-THÉ, G., Clifford, P., And Ho, H. C., Epstein-Barr associated antibody patterns in carcinoma of the post-nasal space, Clin. Exp. Immunol. 5: 443–459 (1969).Google Scholar
  29. 29.
    Deschryver, A., Klein, G., Henle, G., Henle, W., Cameron, H., Santesson, L., And Clifford, P., Epstein-Barr virus associated serology in malignant disease: Antibody levels to viral capsid antigens (Vca), membrane antigens (MA) and early antigens (EA) in patients with various neoplastic conditions, Int. J. Cancer 9: 353–364 (1972).CrossRefGoogle Scholar
  30. 30.
    Desgranges, C., DE-THÉ, G., Ho, J. H. C., And Ellouz, R., Neutralizing Ebv-specific IgA in throat washings of nasopharyngeal carcinoma (Npc) patients, Int. J. Cancer 19: 627–633 (1977).PubMedCrossRefGoogle Scholar
  31. 31.
    Desgranges, C., LI, J. Y., And DE-THÉ, G., Ebv specific secretory IgA in saliva of Npc patients: Presence of secretory piece in epithelial malignant cells, Int. J. Cancer 20: 881–886 (1977).PubMedCrossRefGoogle Scholar
  32. 32.
    Desgranges, C., Wolf, H., DE-THÉ, G., Shanmugaratnam, K., Ellouz, R., Cammoun, N., Klein, G., And Zur Hausen, H., Nasopharyngeal carcinoma X-Presence of Epstein-Barr genomes in epithelial cells of tumours from high and medium risk areas, Int. J. Cancer 16: 7–15 (1975).PubMedCrossRefGoogle Scholar
  33. 33.
    de-Thé, G., Is Burkitt’s lymphoma (BL) related to a perinatal infection by Epstein-Barr virus? Lancet 1: 335–338 (1977).PubMedCrossRefGoogle Scholar
  34. 34.
    de-Thé, G., Epstein-Barr virus: Is it time to discuss a vaccine? Biomed. Comm. 28: 15–17 (1978).Google Scholar
  35. 35.
    de-Thé, G., The epidemiology of Burkitt’s lymphoma: Evidence for a causal association with Epstein-Barr virus-a review, Am. J. Epidemiol. 1: 32–57 (1979).Google Scholar
  36. 36.
    de-Thé, G., The role of the Epstein-Barr virus in human diseases: Infectious mononucleosis (IM), Burkitt’s lymphoma (BL), nasopharyngeal carcinoma (Npc), in: Viral Oncology (G. Klein, ED.), pp. 769–797, Raven Press, New York, 1979.Google Scholar
  37. 37.
    de-Thé, G., Multistep carcinogenesis, Epstein-Barr virus and human malignancies, in: Viruses in Naturally Occurring Cancers (M. Essex, G. Todarg, And H. Zur Hausen, Eds.), pp. 11–21, Cold Spring Harbor Conferences on Cell Proliferation, Vol. 7, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, 1980.Google Scholar
  38. 38.
    de-Thé, G., Epidemiology, pathogenesis and prevention of Ebv associated malignancies, in: The Epstein-Barr virus and associated diseases: Proceedings of the Vth International Symposium (T. Tursz, J. S. Pagano, D. V. Ablashi, G. DE THÉ, G. Lenoir, And G. R. Pearson, Eds.), pp. 15–30, Colloques Inserm/John Libbey Eurotext Ltd., Paris, 1993.Google Scholar
  39. 39.
    de-Thé, G., Ablashi, D. V., Liabeuf, A., And MoUrali, N., Nasopharyngeal carcinoma (Npc). VI. Presence of an Ebv nuclear antigen in fresh tumour biopsies: Preliminary results, Biomedicine 19: 349–352 (1973).PubMedGoogle Scholar
  40. 40.
    de-Thé, G., Ambrosioni, J. C., Ho, H. C., And Kwan, H. C., Lymphoblastoid transformation and presence of herpes-types viral particles in a Chinese nasopharyngeal tumour cultured in vitro, Nature 221: 770–771 (1969).PubMedCrossRefGoogle Scholar
  41. 41.
    de-Thé, G., Day, N. E., Geser, A., Ho, J. H. C., Lavoue, M. F., Simons, M. J., Sohiba, R., And TuxBI, P., Epidemiology of the Epstein-Barr virus: Preliminary analysis of an international study, in: Oncogenisis and Herpesviruses 11 (G. DE-THÉ, M. A. Epstein, And H. Zur Hausen, Eds.), pp. 3–16, Iarc Scientific Publication No. 11, Vol. 2, Iarc, Lyon, France, 1975.Google Scholar
  42. 42.
    de-Thé, G., Desgranges, C., Zeng, Y., Wang, P. C., Born-Kamm, G. W., Zhu, J. S., And Shang, M., Search for pre-cancerous lesions and Ebv markers in the nasopharynx of IgA positive individuals, in: Nasopharyngeal Carcinoma, Vol. 5 (E. Grundmann, G. R. E Xrueger, And D. V. Ablash, Eds.), pp. 111–117, Gustav Fisher Verlag, Stuttgart, 1981.Google Scholar
  43. 43.
    de-Thé, G., DE-Vathaire, F., Sancho-Garnier, H., DE-THÉ, H., Schwaab, G., Micheau, C., Bschweou, F., Roche, N., Ellouz, R., And Ho, J. H. C., IgA/EA: Prognostic marker for relapse among Npc patients with complete remission after radiotherapy, in: Epstein-Barr Virus and Human Diseases (P. Levine, D. Ablashi, And G. Pearson, Eds.), pp. 43–45, Humana Press, Clifton, NJ, 1987.Google Scholar
  44. 44.
    de-Thé, G., Geser, A., Day, N. E., Tukei, R. M., Williams, E. H., Beri, D. R, Smith, R G., Dean, A. G., BoRnkamm, G. W., Feorino, R., And Henle, W., Epidemiological evidence for causal relationship between Epstein-Barr virus and Burkitt’s lymphoma from Ugandan prospective study, Nature 274: 756–761 (1978).PubMedCrossRefGoogle Scholar
  45. 45.
    de-Thé, G., Ho, H. C., Kwan, H. C., Desgranges, C., And Favre, M. C., Nasopharyngeal carcinoma (Npc). I. Types of cultures derived from tumour biopsies and non-tumorous tissues of Chinese patients with special reference to lymphoblastoid transformation, Int. J. Cancer 6: 189–206 (1970).PubMedCrossRefGoogle Scholar
  46. 46.
    de-Thé, G., Ho, J. H. C., Ablashi, D. V., Day, N. E., Macario, A. J. L., Martin-Berthelon, M. C., Pearson, G., And Sohier, R., Nasopharyngeal carcinoma IX. Antibodies to Eban and correlation with response to other Ebv antigens in Chinese patients, Int. J. Cancer 16: 713–721 (1975).PubMedCrossRefGoogle Scholar
  47. 47.
    de-Thé, G., LavquÉ, M. E, And Muenz, I., Differences in Ebv antibody titres of patients with nasopharyngeal carcinoma originating from high, intermediate and low incidence areas, in: Nasopharyngeal Carcinoma: Etiology and Control (G. DE-THÉ And Y. ITo, EDs.), pp. 471–481, Iarc Scientific Publication No. 20, Iarc, Lyon, France, 1978.Google Scholar
  48. 48.
    de-Thé, G., Sohier, R., Ho, J. H. C., And Freund, R., Nasopharyngeal carcinoma IV. Evolution of complement fixing antibodies during the course of the disease, Int. J. Cancer 12: 368–377 (1973).PubMedCrossRefGoogle Scholar
  49. 49.
    de-Thé, G., Vuillaumi, M., Giovanella, A. B. C., And Klein, G., Epithelial characteristics of tumour cells in nasopharyngeal carcinoma (Npc) passaged in nude mice-an ultrastructural study, J. Natl. Cancer Inst. 57: 1101–1105 (1976).PubMedGoogle Scholar
  50. 50.
    de-Thé, G., And Zeng, Y., Population screening for Ebv markers toward improvement of nasopharyngeal carcinoma, in: The Epstein-Barr Virus Recent Advances (M. A. Epstein And B. G. Achong, Eds.), pp. 236–249, William Heinemann Medical Books, London, 1986.Google Scholar
  51. 51.
    DE Vathaire, E, Sancho-Garnier, H., DE-THÉ, H., PuoDeloup, C., Schwaab, G., Ho, J. H. C., Ellouz, R., Michrau, C., Cammoun, M., Cachin, Y., And DE-THÉ, G., Prognostic value of Ebv markers in the clinical management of nasopharyngeal carcinoma: A multicenter follow-up study, Int. J. Cancer 42: 176–181 (1988).CrossRefGoogle Scholar
  52. 52.
    Digby, K. H., Thomas, G. H., And Hstu, S. T., Notes on carcinoma of the nasopharynx, Caduceus 9: 45–64 (1930).Google Scholar
  53. 53.
    Dobson, W. C., Cervical lymphosarcoma (letter to the editor), Chin. Med. J. 38: 786 (1924).Google Scholar
  54. 54.
    Doll, R., Epidemiology of cancer: Current perspectives, Am. J. Epidemiol. 104: 396–408 (1976).PubMedGoogle Scholar
  55. 55.
    Durand-Fardel, Cancer du pharynx-Ossification dans is substance musculaire du coeur, Bull. Soc. Anat. (Paris) 12: 73–80 (1837).Google Scholar
  56. 56.
    Epstein, M. S., The Epstein-Barr virus: Retrospective reflections and future prospects, in: The Epstein-Barr virus and associated diseases: Proceedings of the Vth International Symposium (T. Tursz, J. S. Pagano, D. V. Ablashi, G. DE THÉ, G. Lenoir, And G. R. Pearson, Eds.), pp. 3–14, Colloques Inserm/John Libbey Eurotext Ltd., Paris, 1993.Google Scholar
  57. 57.
    Epstein, M. A., And Achong, B. G., Recent progress in BB virus research, Annu. Rev. Microbiol. 31: 421–415 (1977).PubMedCrossRefGoogle Scholar
  58. 58.
    Epstein, M. A., Achong, B. G., And Barr, Y. M., Virus particles in cultured lymphoblasts from Burkitt’s lymphoma, Lancet 1: 702–703 (1964).PubMedCrossRefGoogle Scholar
  59. 59.
    Epstein, M. A., Morgan, A. J., Finerty, S., Randle, B. J., And Kirkwood, J. K., Protection of cottontop tamarins against EB virus-induced malignant lymphoma by a prototype subunit vaccine against MP gp 340, Nature 318: 287–289 (1985).PubMedCrossRefGoogle Scholar
  60. 60.
    Evans, A. S., The history of infectious mononucleosis, Am. J. Med. Sci. 267: 189–195 (1974).PubMedCrossRefGoogle Scholar
  61. 61.
    Evans, A. S., New discoveries in infectious mononucleosis, Mod. Med. 1: 18–24 (1974).Google Scholar
  62. 62.
    Evans, A. S. Ebv vaccine: Use in infectious mononucleosis, in: The Epstein-Barr virus and associated diseases: Proceedings of the Vth International Symposium (T. Tursz, J. S. Pagano, D. V. Ablashi, G. DE THÉ, G. Lenoir, And G. R. Pearson, Eds.), pp. 593–598, Colloques Inserm/John Libbey Eurotext Ltd., Paris, 1993.Google Scholar
  63. 63.
    Evans, A. S., And Niederman, J. C., Epidemiology of infectious mononucleosis, in: Oncogenesis and Herpesviruses (P. M. Blocs, G. DE-THÉ, And L. N. Payne, Eds.), pp. 351–356, Iarc Scientific Publication No. 2, Iarc, Lyon, France, 1972.Google Scholar
  64. 64.
    Fong, Y. Y., And Chan, W. C., Bacterial production of dimethyl nitrosamine in salted fish, Nature 243: 421–422 (1973).PubMedCrossRefGoogle Scholar
  65. 65.
    Fong, Y. Y., And Walsh, E. O., Carcinogenic nitrosamines in Cantonese salt-dried fish, Lancet 1: 1032–1033 (1971).CrossRefGoogle Scholar
  66. 66.
    Fraumeni, J. E, JR., And Mason, T. J., Cancer mortality among Chinese Americans, 1950–69, J. Natl. Cancer Inst. 52: 659–665 (1974).PubMedGoogle Scholar
  67. 67.
    Gallo, R. C., Saxinger, W. C., Gallagher, R. E., Gillespie, D. A., Aulakh, G. S., And WO NG-Staal, E, Some ideas on the origin of leukemia in man and recent evidence for the presence of type-C viral related information, in: Origins of Human Cancer (H. Hiatt, J. D. Watson, And J. A. Winsten, Eds.), Cold Spring Harbor Conferences on Cell Proliferation, Vol. 4, Book B, pp. 1253–1285, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, 1977.Google Scholar
  68. 68.
    Gazzolo, L., DE-THÉ, G., And Vuillaume, M., Nasopharyngeal carcinoma, II. Ultrastructure of normal mucosa, tumor biopsies and subsequent epithelial growth in vitro, J. Natl. Cancer Inst. 48: 73–86 (1972).PubMedGoogle Scholar
  69. 69.
    Gerber, E, And Birch, S., Complement-fixing antibodies in sera of human and non-human primates to viral antigens derived from Burkitt’s lymphoma cells, Proc. Natl. Acad. Sci. Usa 58: 478484 (1967).Google Scholar
  70. 70.
    Gerber, P., Nonoyama, M., Lucas, S., Perlin, E., And Gold-Stein, L., Oral excretion of Ebv by healthy subjects and patients with infectious mononucleosis, Lancet 2: 988–989 (1972).PubMedCrossRefGoogle Scholar
  71. 71.
    Gerber, P., Whang-Peng, J., And Monroe, J., Transformation and chromosome changes induced by Epstein-Barr virus in normal human leukocyte cultures, Proc. Natl. Acad. Sci. Usa 63: 740–747 (1969).CrossRefGoogle Scholar
  72. 72.
    Geser, A., Charnay, N., Day, N. E., DE-THÉ, G., And Ho, H. C., Environmental factors in the etiology and nasopharyngeal carcinoma: Report on a case-control study in Hong Kong, in: Nasopharyngeal Carcinoma: Etiology and Control (G. DE-THÉ Andy. ITo, Eds.), pp. 213–229, Iarc Scientific Publication No. 20, Iarc, Lyon, France, 1978.Google Scholar
  73. 73.
    Geser, A., Day, N. E., DE-THÉ, G., Chew, T. S., Freund, R. J., Kwan, H. C., LavouÉ, M. E, Simkovic, D., And Sohier, R., The variability in immunofluorescent viral capsid antigen antibody testing in population survey of Epstein-Barr virus infection, Bull. Who 50: 389–400 (1974).PubMedGoogle Scholar
  74. 74.
    Glaser, R., DE-THÉ, G., Lenoir, G., And Ho, J. H. C., Super-infection of nasopharyngeal carcinoma epithelial tumour cells with Epstein-Barr virus, Proc. Natl. Acad. Sci. Usa 73: 960–963 (1976).PubMedCrossRefGoogle Scholar
  75. 75.
    Goldenberg, G. J., Brandes, L. J., Lau, W. H., Miller, A. B., Wall, C., And Ho, J. H. C., Cooperative trial of immunotherapy for nasopharyngeal carcinoma with transfer factor from donors with Epstein-Barr virus antibody activity, Cancer Treat. Rep. 69: 761–767 (1985).PubMedGoogle Scholar
  76. 76.
    Green, M. H., Fraumeni, J. E, JR., And Hoover, R., Nasopharyngeal cancer among young in United States: Racial variations by cell type, J. Natl. Cancer Inst. 58: 1267–1270 (1977).Google Scholar
  77. 77.
    Hawkins, B. R., Simons, M. J., Goh, E. H., Chia, K. B., And Shanmugaratnam, K., Immunogenetic aspects of nasopharyngeal carcinoma. II. Analysis of Abo, Rhesus and Mns’s red cell systems, Int. J. Cancer 13: 116–121 (1974).PubMedCrossRefGoogle Scholar
  78. 78.
    Henderson, B. E., And Louie, E., Discussion of risk factors for nasopharyngeal carcinoma, in: Nasopharyngeal Carcinoma: Etiology and Control (G. DE-THÉ And Y. ITo, Eds.), pp. 251–260, Iarc Scientific Publication No. 20, Iarc, Lyon, France, 1978.Google Scholar
  79. 79.
    Henderson, B. E., Loum, E., Jing, J. S. H., Buell, P., And Gardner, M. B., Risk factors associated with nasopharyngeal carcinoma, N. Engl. J. Med. 295: 1101–1106 (1976).PubMedCrossRefGoogle Scholar
  80. 80.
    Henle, G., Antibodies to Ebv-induced early antigens in infectious mononucleosis, Burkitt’s lymphoma and nasopharyngeal carcinoma, in: Recent Advances in Human Tumor Virology and Immunology (W. Nakahara, K. Nishoica, T. Hirayama, And T. Iro, EDs.), pp. 343–359, University of Tokyo, 1971.Google Scholar
  81. 81.
    Henle, G., And Henle, W., Immunofluorescence in cells derived from Burkitt’s lymphoma, J. Bacteriol. 91: 1248–1256 (1966).PubMedGoogle Scholar
  82. 82.
    Henle, G., And Henle, W., Epstein-Barr virus-specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinoma, Int. J. Cancer 17: 1–7 (1976).PubMedCrossRefGoogle Scholar
  83. 83.
    Henle, G., Henle, W., And Klein, G., Demonstration of two distinct components in the early antigen complex of Ebv infected cells, Int. J. Cancer 8: 272–282 (1971).PubMedCrossRefGoogle Scholar
  84. 84.
    Henle, W., And Henle, G., Epstein-Barr virus: The cause of infectious mononucleosis, in: Oncogenesis and Herpesviruses (P. M. Biggs, G. DE-THÉ, And L. N. Payne, Eds.), pp. 269–274, Iarc Scientific Publication No. 2, Iarc, Lyon, France, 1972.Google Scholar
  85. 85.
    Henle, W., And Henle, G., Epstein-Barr virus and infectious mononucleosis, N. Engl. J. Med. 288: 263–264 (1978).CrossRefGoogle Scholar
  86. 86.
    Henle, W., Henle, G., Burtin, P., Cachin, Y., Clifford, P., DE Schryver, A., DE-THÉ, G., Diehl, V., Ho, H. C., And Klein, G., Antibodies to Epstein-Barr virus in nasopharyngeal carcinoma, other head and neck neoplasms and control groups, J. Natl. Cancer Inst. 44: 225–231 (1970).PubMedGoogle Scholar
  87. 87.
    Henle, W., Henle, G., Zajac, B. A., Pearson, G., Waubke, R., And Scriba, M., Differential reactivity of human serums with early antigens induced by Epstein-Barr virus, Science 169: 188–190 (1970).PubMedCrossRefGoogle Scholar
  88. 88.
    Henle, W., Ho, H. C., And KwAN, H. C., Antibodies to Epstein-Barr virus related antigens in nasopharyngeal carcinoma: Comparison of active cases with long-term survivors, J. Natl. Cancer Inst. 51: 361–369 (1973).PubMedGoogle Scholar
  89. 89.
    Higginson, J., DE-THÉ, G., Geser, A., And Day, N. E., An epidemiological analysis of cancer vaccines, Int. J. Cancer 7: 565–574 (1971).PubMedCrossRefGoogle Scholar
  90. 90.
    Higginson, J., And Maclennan, R., The world pattern of cancer incidence, in: Modern Trends in Oncology-Research Progress (R. W. Raven, ED.), pp. 9–27, Butterworths, London, 1973.Google Scholar
  91. 91.
    HO, H. C., Nasopharyngeal carcinoma in Hong Kong, in: Cancer of the Nasopharynx (C. S. Muni And K. Shanmugaratnam, Eds.), pp. 58–63, Uicc Monograph Series, Vol. 1, Munksgaard, Copenhagen, 1967.Google Scholar
  92. 92.
    HO, H. C., Incidence of nasopharyngeal cancer in Hong Kong, Uicc Bulletin, Cancer 9 (2): 5–8 (1971).Google Scholar
  93. 93.
    HO, H. C., Radiologic diagnosis of nasopharyngeal carcinoma with special reference to its spread through the base of skull, in: Cancer of the Nasopharynx (C. S. MuIR And K. Shanmugaratnam, Eds.), pp. 238–246, Uicc Monograph Series, Vol. 1, Medical Examination Publishing, New York, 1972.Google Scholar
  94. 94.
    HO, H. C., Head and neck-Radiologic diagnosis, J.A.M.A. 220: 396 (1972).PubMedCrossRefGoogle Scholar
  95. 95.
    HO, H. C., Current knowledge of the epidemiology of nasopharyngeal carcinoma-a review, in: Oncogenesis and Herpesviruses (P. M. Biggs, G. DE-THÉ, And L. N. Payne, Eds.), pp. 357–366, Iarc Scientific Publication No. 2, Iarc, Lyon, France, 1972.Google Scholar
  96. 96.
    HO, H. C., Epidemiology of nasopharyngeal carcinoma (Npc), in: Proceedings of the 1st Asian Cancer Conference (H. HnuYama, ED.), pp. 357–366, Shima, Tokyo, 1973.Google Scholar
  97. 97.
    HO, H. C., Epidemiology of nasopharyngeal carcinoma, J. R. Coll Surg. (Edinburgh) 20: 223–235 (1975).Google Scholar
  98. 98.
    HO, H. C., Kwan, H. C., And NG, M. H., Immunohisto-chemistry of local immunoglobulin production in nasopharyngeal carcinoma, Br. J. Cancer 37: 514–519 (1978).PubMedCrossRefGoogle Scholar
  99. 99.
    HO, H. C., Kwan, H. C., NG, M. H., And DE-THÉ, G., Serum IgA antibodies to Epstein-Barr virus capsid antigen preceding symptoms of nasopharyngeal carcinoma, Lancet 1: 436–437 (1978).PubMedCrossRefGoogle Scholar
  100. 100.
    HO, H. C., NG, M. H., And KwAN, H. C., IgA antibodies to Epstein-Barr virus viral capsid antigens in saliva of nasopharyngeal carcinoma patients, Br. J. Cancer 35: 888–890 (1977).PubMedCrossRefGoogle Scholar
  101. 101.
    HO, J. H. C., The natural history and treatment of nasopharyngeal carcinoma (Npc), in: Oncology. Vol. 4, Proceedings of the 10th International Cancer Congress (R. Lee-Clark, R. W. CuMley, J. E. Mccay, And M. Copeland, Eds.), pp. 1–14, Year Book Medical Publishers, Chicago, 1970.Google Scholar
  102. 102.
    HO, J. H. C., Genetic and environmental factors in nasopharyngeal carcinoma, in: Recent Advances in Human Tumor Virology and Immunology, Proceedings of the First International Cancer Symposium of the Princess Takamatsu Cancer Research Fund (W. Nakahara, K. Nishiuka, T. Hirayama, And Y. Ito, Eds.), pp. 275–295, University of Tokyo Press, Tokyo, 1971.Google Scholar
  103. 103.
    HO, J. H. C., Nasopharyngeal carcinoma (Npc), in: Advances in Cancer Research (G. Klein, S. Weinhouse, And A. Haddow, Eds.), pp. 57–92, Academic Press, New York and London, 1972.Google Scholar
  104. 104.
    HO, J. H. C., An epidemiologic and clinical study of nasopharyngeal carcinoma, Int. J. Radiat. Oncol. Biol. Phys. 4: 181–198 (1978).CrossRefGoogle Scholar
  105. 105.
    HO, J. H. C., Cancer in Hong Kong: Some epidemiological observations, in: Third Symposium on Epidemiology and Cancer Registries in the Pacific Basin Held in Maui, Hawaii, January 1923, 1981, pp. 37–54, Nci Monograph 62, Nih, Bethesda, MD, 1982.Google Scholar
  106. 106.
    HO, J. H. C., Huang, D. P., And Fong, Y. Y., Salted fish and nasopharyngeal carcinoma in southern Chinese, Lancet 1: 626–628 (1978).CrossRefGoogle Scholar
  107. 107.
    HO, J. H. C., NG, M. H., Kwan, H. C., And Chan, J. C. W., Epstein-Barr virus specific IgA and IgG serum antibodies in nasopharyngeal carcinoma, Br. J. Cancer 34: 655–660 (1976).PubMedCrossRefGoogle Scholar
  108. 108.
    HU, C. H., And Yang, C., A decade of progress in morphologic pathology, Chin. Med. J. 79: 409–422 (1959).PubMedGoogle Scholar
  109. 109.
    Huang, D. P., Gough, T., And Ho, J. H. C., Analysis for volatile nitrosamines of salt-preserved foodstuffs traditionally consumed by southern Chinese, in: Nasopharyngeal Carcinoma: Etiology and Control (G. DE-THÉ And Y. ITo, EDs.), pp. 309–314, Iarc Scientific Publication No. 20, Iarc, Lyon, France, 1978.Google Scholar
  110. 110.
    Huang, D. P., Ho, J. H. C., Henle, W., And Henle, G., Demonstration of Epstein-Barr virus-associated nuclear antigen in nasopharyngeal carcinoma cells from fresh biopsies, Int. J. Cancer 14: 580–588 (1974).PubMedCrossRefGoogle Scholar
  111. 111.
    Huang, D. E, Saw, D., Teoh, T. B., And Ho, J. H. C., Carcinomas in rats fed with Cantonese salted marine fish, in: Nasopharyngeal Carcinoma: Etiology and Control (G. DE-THÉ Andy. Ito, Ens.), pp. 315–328, Iarc Scientific Publication No. 20, Iarc, Lyon, France, 1978.Google Scholar
  112. 112.
    Hubert, A., And DE-THÉ, G., Comportement alimentaire, modes de vie et cancer du rhinopharynx (Npc), Bull. Cancer (Paris) 69 (5): 476–482 (1982).Google Scholar
  113. 113.
    Hubert, A., Jeannel, D., Tuppin, P, And DE-THÉ, G., Anthropology and epidemiology: A pluridisciplinary approach of environmental factors of nasopharyngeal carcinoma, in: The Epstein-Barr virus and associated diseases: Proceedings of the Vth International Symposium (T. Tursz, J. Pagano, G. DE-The, D. Ablashi, G. Lenoir, And G. Pearson, Eds.), pp. 775–788, Inserm and John Libbey Eurotext, Paris, 1993.Google Scholar
  114. 114.
    International Agency For Research ON Cancer (Iarc), Cancer Incidence in Five Continents, Vol. Iii (J. Waterhouse, C. S. Mum, P. Correa, And G. Powell, Eds.), Iarc Scientific Publication No. 15, Iarc, Lyon, France, 1976.Google Scholar
  115. 115.
    International Agency For Research ON Cancer (Iarc), Nasopharyngeal Carcinoma: Etiology and Control, (G. DE-THÉ And Y. ITo, Ens.), Iarc Scientific Publication No. 20, Iarc, Lyon, France, 1978.Google Scholar
  116. 116.
    International Agency For Research ON Cancer (Iarc), Annual Report, pp. 75–76, Iarc Lyon, France, 1978.Google Scholar
  117. 117.
    International Union Against Cancer [Union International Contre LE Cancer (Uicc)], Cancer of the Nasopharynx, Monograph Series, Vol. 1. (C. S. Muir And K. Shanmugaratnam, Eds.), Munksgaard, Copenhagen, 1967.Google Scholar
  118. 118.
    Jeannel, D., Ghnassia, M., Hubert, A., Sancho-Garnier, H., Crognier, E., And DE-THÉ, G., Increased risk of undifferentiated nasopharyngeal carcinoma among males of French origin born in North Africa (Maghreb), Int. J. Cancer 54: 536–539 (1993).PubMedCrossRefGoogle Scholar
  119. 119.
    Jeannel, D., Hubert, A., DE-Vathaire, F., Ellouz, R., Cammoun, M., Ben Salem, M., Sancho-Garnier, H., And DE-THÉ, G., Diet, living conditions and nasopharyngeal carcinoma in Tunisia. A case control study, Int. J. Cancer 46: 421–425 (1990).PubMedCrossRefGoogle Scholar
  120. 120.
    Jondal, M., And Klein, G., Classification of lymphocytes in nasopharyngeal carcinoma (Npc) biopsies, Biomedicine 23: 163165 (1975).Google Scholar
  121. 121.
    Jung, P. F., And Yu, C., Nasopharyngeal cancer in China, Postgrad. Med. 33: A77 - A82 (1963).PubMedGoogle Scholar
  122. 122.
    King, H., And Haenszel, K., Cancer mortality among foreign and native-born Chinese in the United States, J. Chron. Dis. 26: 623–646 (1972).CrossRefGoogle Scholar
  123. 123.
    Kirk, R. L., Blake, N. M., Serjeantson, S., Simons, M. J., And Chan, S. H., Genetic components in susceptibility to nasopharyngeal carcinoma, in: Nasopharyngeal Carcinoma: Etiology and Control, (G. DE-THÉ And Y. ITo, Eds.), pp. 283–297, Iarc Scientific Publication No. 20, Iarc, Lyon, France, 1978.Google Scholar
  124. 124.
    Klein, G., Ebv associated membrane antigens, in: Oncogenesis and Herpesviruses (P. M. Biggs, G. DE-THÉ, And L. N. Payne, Eds.), pp. 295–301, Iarc Scientific Publication No. 2, Iarc, Lyon, France, 1972.Google Scholar
  125. 125.
    Klein, G., The Epstein-Barr virus, in: The Herpesviruses (A. Kaplan, ED.), pp. 521–555, Academic Press, New York, 1973.Google Scholar
  126. 126.
    Klein, G., Viral Oncology, Raven Press, New York, 1979.Google Scholar
  127. 127.
    Klein, G., Clifford, P., Klein, E., And StjernswÄRD, J., Search for tumor-specific immune reactions in Burkitt lymphoma patients by the membrane immunofluorescence reaction, Proc. Natl. Acad., Sci. Usa 55: 1628–1635 (1966).CrossRefGoogle Scholar
  128. 128.
    Klein, G., Giovanella, B. C., Lindahl, T., Fialkow, P. J., Singh, S., And Stehlin, J., Direct evidence for the presence of Epstein-Barr virus Dna and nuclear antigen in malignant epithelial cells from patients with anapiastic carcinoma of the nasopharynx, Proc. Natl. Acad. Sci. Usa 71: 4737–4741 (1974).PubMedCrossRefGoogle Scholar
  129. 129.
    Klein, G., Pearson, G., Henle, G., Henle, W., Diehl, V., And Niederman, J. C., Relation between Epstein-Barr viral and cell membrane immunofluorescence in Burkitt tumor cells. I. Dependence of cell membrane immunfluorescence on presence of EB virus, J. Exp. Med. 128: 1011–1020 (1968).PubMedCrossRefGoogle Scholar
  130. 130.
    Klein, G., And Vonka, V., Relationship between the Epstein-Barr virus (Ebv) determined, complement fixing antigen and the nuclear antigen (Ebna) detected by anti-complement fluorescence, hit. J. Cancer 53: 1645–1646 (1974).Google Scholar
  131. 131.
    Kmet, J., And Mahboubi, E., Esophageal cancer in the Gaspian littoral of Iran: Initial studies, Science 175: 846–853 (1972).PubMedCrossRefGoogle Scholar
  132. 132.
    Krogman, W. M., The skeletal and dental pathology of an early Iranian site, Bull. Hist. Med. 8: 28–48 (1940).Google Scholar
  133. 133.
    Laufs, R., Immunisation of marmoset monkeys with a killed oncogenic herpesvirus, Nature 249: 571–572 (1974).PubMedCrossRefGoogle Scholar
  134. 134.
    Lemaigre, G., Diebold, J., Temmim, L., Arseniev, L., Lecharpentier, Y., Allouache, A., Delaitre, B., And Abelanet, R., Carcinome du nasopharynx chez les sujets jeunes-Étude clinique, anatomique et ultrastructurale de 50 cas observés dans l’est algérien, Nouv. Press Med. 6: 3509–3513 (1977).Google Scholar
  135. 135.
    Lemon, S. M., Hutt, L. M., Shaw, J., LI, J. L., And Pagano, J., Replication of Ebv in epithelial cells during infectious mononucleosis, Nature 268: 268–270 (1977).PubMedCrossRefGoogle Scholar
  136. 136.
    Lenoir, G., Martin-Berthelon, M. C., Favre, M. C., And DE-THÉ, G., Characterization of Ebv antigens. I. Biochemical analysis of the complement-fixing soluble antigen and relationship with Ebna, J. Viral. 17: 672–674 (1976).Google Scholar
  137. 137.
    Levine, P., Cho, B., Connelly, R., DE Vita, C., Berard, C., O’ConoR, G., And Dorhman, R., The American Burkitt’s lymphoma registry: A progress report, Ann. Intern. Med. 83: 82–83 (1975).CrossRefGoogle Scholar
  138. 138.
    Levine, P. H., DE-THÉ, G., Brugere, J., Schwaab, G., Mourali, N., Heberman, R. B., Ambrosioni, J. C., And Revol, P., Immunity to antigens associated with a cell line derived from nasopharyngeal carcinoma (Npc) in non-Chinese Npc patients, Int. J. Cancer 17: 155–160 (1976).Google Scholar
  139. 139.
    Levine, P. H., Lubin, J. H., And Evans, A. S., An Epstein-Barr virus (Ebv) vaccine: Evaluating the efficacy of an Ebv vaccine: Clinical and epidemiologic considerations, in: The Epstein-Barr virus and associated disease: Proceedings of the Vth International Symposium, (T. Tursz, J. S. Pagano, D. V. Ablashi, G. DE THÉ, G. Lenoir, And G. R. Pearson, Eds.), pp. 585–592, Colloques Inserm/John Libbey Eurotext, Paris, 1993.Google Scholar
  140. 140.
    Lang, P. C., Studies on nasopharyngeal carcinoma in the Chinese: Statistical and laboratory investigation, Chin. Med. J. 83: 373–390 (1964).Google Scholar
  141. 141.
    Lilly, E, The inheritance of susceptibility of the Gross leukemia virus in mice, Genetics 53: 529–539 (1966).PubMedGoogle Scholar
  142. 142.
    Lilly, E, Mouse leukemia: A model of a multiple-gene disease, J. Natl. Cancer Inst. 49: 927–934 (1972).PubMedGoogle Scholar
  143. 143.
    Lin, T. M., Chen, K. P., Lin, C. C., Hsu, M. M., Tv, S. M., Chang, T. C., Jung, P. F., And Hirayama, T., Retrospective study on nasopharyngeal carcinoma, J. Natl. Cancer Inst. 51: 1403–1408 (1975).Google Scholar
  144. 144.
    Lin, T. M., Hsu, M. M., Cheng, K. P., Chiang, T. C., Jung, P. E, And Hirayama, T., Morbidity and mortality of cancer of the nasopharynx in Taiwan, Gann Monogr. 10: 137–144 (1972).Google Scholar
  145. 145.
    Linsell, C A, Cancer in Kenya, in: Cancer in Africa (P. Clwford, C. A. Linsell, And G. L. Timms, Eds.), pp. 7–12, East African Publishing House, Nairobi, 1968.Google Scholar
  146. 146.
    Lu, S. J., Day, N. E., Degos, I., Lepage, V., Wang, P. H., Chan, S., Simons, H., Macknight, B., Easton, D., Zend, Y., DE-THÉ, G., The genetic basis for carcinoma of the nasopharynx (Npc): Evidence to linkage to the Hla region, Nature 346: 470–471 (1990).PubMedCrossRefGoogle Scholar
  147. 147.
    Mathew, G. D., Qualtiere, L. E, Neel, H. 13., Iii, And Pear-Son, G. R., IgA antibody, antibody-dependent cellular cytotoxicity and prognosis in patients with nasopharyngeal carcinoma, Int. J. Cancer 27: 175–180 (1981).PubMedCrossRefGoogle Scholar
  148. 148.
    McDevitt, H. O., ANo Bodmer, W. J., HL-A, immune response genes, and disease: Occasional survey, Lancet 1: 1269–1275 (1974).Google Scholar
  149. 149.
    Michaux, L., Carcinome de base du crane, cited by Godtfredson, E., Ophthalmologic and neurologic symptoms of malignant nasopharyngeal tumours: Clinical study comprising 454 cases, with special reference to histo-pathology and possibility of earlier recognition, Acta Psychiatr. Scand. Suppl. 34: 1–323 (1944).Google Scholar
  150. 150.
    Miller, G., Niederman, J. C., And Still, D. A., Infectious mononucleosis: Appearance of neutralizing antibody to Epstein-Barr virus measured by inhibition of formation of lymphoblastoid cell lines, J. Infect. Dis. 125: 403–406 (1972).PubMedCrossRefGoogle Scholar
  151. 151.
    Morgan, A. J., Epstein-Barr virus vaccines, in: Vaccine 10 (9): 563–571 (1992).Google Scholar
  152. 152.
    Morgan, A. J., Recent progress in EB vaccine development, in: Vth International Symposium on Epstein-Barr Virus and Associated Diseases, (Ebv and Human Diseases-1992) (T. Tursz, J. Pagano, G. DE-THÉ, M. Ablashi, G. Lenoir, And G. Pearson, Eds.), pp. 231–235, Inserm and John Libbey Eurotext, Paris, 1993.Google Scholar
  153. 153.
    Muir, C. S., Nasopharyngeal carcinoma in non-Chinese populations with special reference to South East Asia and Africa, Int. J. Cancer 8: 351–363 (1971).PubMedGoogle Scholar
  154. 154.
    Muir, C. S., Nasopharyngeal carcinoma in non-Chinese populations, in: Oncogenesis and Herpesviruses (P. M. Biggs, G. DE-THÉ, And L. N. Payne, Eds.), pp. 367–371, Iarc Scientific Publication No. 2, Iarc, Lyon, France, 1972.Google Scholar
  155. 155.
    Muni, C. S., Geographical differences in cancer patterns, in: Host Environmental Interactions in the Etiology of Cancer in Men (R. Doll And I. Vodopua, Eds.), pp. 1–13, Iarc Scientific Publication No. 7, Iarc, Lyon, France, 1973.Google Scholar
  156. 156.
    Muir, C. S., And Oakley, W. F., Nasopharyngeal carcinoma in Sarawak (Borneo), J. Laryngol. 81: 197–207 (1967).CrossRefGoogle Scholar
  157. 157.
    Muir, C. S., And Shanmugaratnam, K., The incidence of nasopharyngeal cancer in Singapore, in: Cancer of the Nasopharynx (C. S. Muir And K. Shanmugaratnam, Eds.), pp. 47–53, Uicc Monograph Series, No. 1, Munksgaard, Copenhagen, 1967.Google Scholar
  158. 158.
    Nevo, S., Meyer, W., And Altman, M., Carcinoma of nasopharynx in twins, Cancer 28: 807–809 (1971).PubMedCrossRefGoogle Scholar
  159. 159.
    NG, M. H., And Sham, J. S. T., Development of nasopharyngeal carcinoma: A working hypothesis. Ebv and Human Diseases. Proceeding of the 1992 Ebv meeting, in: The Epstein-Barr virus and associated diseases: Proceedings of the Vth International Symposium (T. Tursz, J. Pagano, G. DE-THÉ, M. Ablashi, G. Lenoir, And G. Pearson, Eds.), pp. 497–506, Inserm and John Libbey Eurotext, Paris, 1993.Google Scholar
  160. 160.
    Niederman, J. C., And Evans, A. S., Infectious mononucleosis, in: Serological epidemiology, (A. S. Evans, ED.), pp. 119–132, Academic Press, New York, 1973.Google Scholar
  161. 161.
    Niedobitek, G., Young, L. S., Sam, C. K., Brooks, L., Prasad, U., And Rickinson, A. B., Expression of Epstein-Barr virus genes and of lymphocyte activation molecules in undifferentiated nasopharyngeal carcinomas. Am. J. Pathol. 140: 879–887 (1992).PubMedGoogle Scholar
  162. 162.
    Nielsen, N. H., Mikkelsen, E, And Hart-Hansen, J. P., Naso pharyngeal cancer in Greenland: Incidence in an arctic Eskimo population, Acta Pathol. Macrobiol. Scand. A 85: 850–858 (1977).Google Scholar
  163. 163.
    Nilsson, K., Klein, G., Henle, G., And Henle, W., The role of Ebv in the establishment of lymphoblastoid cell lines from adult and foetal lymphoid tissue, in: Oncogenesis and Herpesviruses (P. M. Biggs, G. DE-THÉ, And L. N. Payne, Eds.), pp. 285–290, Iarc Scientific Publication No. 2, Iarc, Lyon, France, 1972.Google Scholar
  164. 164.
    Nomoyama, M., And Pagano, J. S., Homology between Epstein-Barr viruses Dna and viral Dna from Burkitt’s lymphoma and nasopharyngeal carcinoma determined by Dna-Dna reassociation kinetics, Nature 242: 44–47 (1973).CrossRefGoogle Scholar
  165. 165.
    O’Conor, G. T., Persistent immunological stimulation as a factor in oncogenesis with special reference to Burkitt’s tumor, Am. J. Med. 48: 279–285 (1970).CrossRefGoogle Scholar
  166. 166.
    Old, L. J., Boyse, E. A., Oettigen, H. E, Old, L. J., Boyse, E. A., Oettgen, H. F., DE Harven, E., Geering, C., Williamson, B., And Clifford, L., Precipitating antibody in human serum to an antigen present in cultured Burkitt’s lymphoma cells, Proc. Natl. Acad. Sci. Usa 56: 1699–1704 (1966).PubMedCrossRefGoogle Scholar
  167. 167.
    Pagano, J. S., Huang, C. H., Klein, G., DE-THÉ, G., Shanmugaratnam, K., Simons, M. J., And Yan, C. S., Homology of Epstein-Barr viral Dna in nasopharyngeal carcinoma from Kenya, Taiwan, Singapore and Tunis, in: Oncogenesis and Herpesviruses II (G. DE-THÉ, M. A. Epstein, And H. Zur Hausen, Eds.), pp. 191–193, Iarc Scientific Publication No. 11, Vol. 2, Iarc, Lyon, France, 1975.Google Scholar
  168. 168.
    Pagano, J. S., Huang, C. H., And Levine, P., Absence of Epstein-Barr viral Dna in American Burkitt’s lymphoma, N. Engl. J. Med. 289: 1395–1399 (1973).PubMedCrossRefGoogle Scholar
  169. 169.
    Pearson, G. R., Coates, H. L., Needl, H. B., Levine, P., Ablashi, D., And Easton, J., Clinical evaluation of Ebv serology in American patients with nasopharyngeal carcinoma, in: Nasopharyngeal Carcinoma: Etiology and Control, (G. DE-THÉ And Y. ITo, Fos.), pp. 439–448, Iarc Scientific Publication No. 20, Iarc, Lyon, France, 1978.Google Scholar
  170. 170.
    Pearson, G. R., And Orr, T. W., Antibody-dependent lymphocyte cytotoxicity against cells expressing Epstein-Barr virus antigens, J. Natl. Cancer Inst. 56: 485–488 (1976).PubMedGoogle Scholar
  171. 171.
    Pereira, M. S., Filld, A. M., Blake, J. M., Rodgers, F. G., And Bailey, L. A., Evidence for oral excretion of EB virus in infectious mononucleosis, Lancet 1: 710–711 (1972).PubMedCrossRefGoogle Scholar
  172. 172.
    Peto, R., Epidemiology, multistage models, and short-term mutagenicity tests, in: Origins of Human Cancer (H. Hiatt, J. D. Watson, And J. A. Winsten, Eds.), Cold Spring Harbor Conferences on Cell Proliferation, Vol. 4, Book C, pp. 1403–1428, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, 1977.Google Scholar
  173. 173.
    Poirier, S., Bouvier, G., Malaveille, C, Ohshima, H., Shao, Y. M., Hubert, A., Zeng, Y., DE-THÉ, G., And Bartsch, H., Volatile nitrosamine levels and genotoxicity in food samples from high risk areas for nasopharyngeal carcinoma (Npc) before and after nitrosation, Int. J. Cancer 44: 1088–1094 (1989).PubMedCrossRefGoogle Scholar
  174. 174.
    Poirier, S., Ohshima, H., DE-THÉ, G., Hubert, A., Bourgade, M. C., And Bartsch, H., Volatile nitrosamine levels in common foods from Tunisia, South China and Greenland. High-risk areas for pasopharyngeal carcinoma (Npc), Int. J. Cancer 39: 293–296 (1987).PubMedCrossRefGoogle Scholar
  175. 175.
    PolpNin, I., The ways of life of people with high rates of nasopharyngeal carcinoma, in: Cancer of the Nasopharynx (C. S. Muir And K. Shanmugaratnam, Eds.), pp. 106–111, Uicc Monograph Series, Vol. 1, Munksgaard, Copenhagen, 1967.Google Scholar
  176. 176.
    Reedman, B. M., And Klein, G., Cellular localization of an Epstein-Barr virus (Ebv) associated complement-fixing antigen in producer and nonproducer lymphoblastoid cell lines, Int. J. Cancer 11: 499–520 (1973).PubMedCrossRefGoogle Scholar
  177. 177.
    Reedman, B. M., Klein, G., Pope, J. H., Walters, M. K., Hilgers, J., Smith, S., And Johansson, B., Epstein-Barr virus associated complement fixing and nuclear antigen in Burkitt’s lymphoma biopsies, Int. J. Cancer 13: 755–763 (1974).PubMedCrossRefGoogle Scholar
  178. 178.
    Reedman, B. M., Pope, J. H., And Moss, D. J., Identify of the soluble Ebv associated antigens of human lymphoid cell lines, Int. J. Cancer 9: 172–181 (1972).PubMedCrossRefGoogle Scholar
  179. 179.
    Saad, A., Observations on nasopharyngeal carcinoma in the Sudan, in: Cancer in Africa (C. A. Linsell And G. L. Timms, Ens.), pp. 281–285, East African Publishing House, Nairobi, 1968.Google Scholar
  180. 180.
    Schmauz, R., And Templeton, A. C., Nasopharyngeal cancer in Uganda, Cancer 29: 610–621 (1972).PubMedCrossRefGoogle Scholar
  181. 181.
    Scum’, G. C., And Atkinson, L., Demographic features of the Chinese population in Australia and the relative prevalence of nasopharyngeal cancer among Caucasians and Chinese, in: Cancer of the Nasopharynx (C. S. Muir And K. Shanmugaratnam, Eds.), pp. 64–72, Uicc Monograph Series, Vol. 1, Munksgaard, Copenhagen, 1967.Google Scholar
  182. 182.
    Shanmugaratnam, K., Nasopharyngeal carcinoma in Asia, in: Racial and Geographical Factors in Tumour Incidence (A. A. Shivas, ED.), pp. 169–188, Pfizer Medical Monograph, Vol. 2, Edinburgh University Press, Edinburgh, 1967.Google Scholar
  183. 183.
    Shanmugaratnam, K., Studies on the etiology of nasopharyngeal carcinoma, Int. Rev. Exp. Pathol. 10: 361–413 (1971).PubMedGoogle Scholar
  184. 184.
    Shanmugaratnam, K., Cancer in Singapore-Ethnic and dialect group variations in cancer incidence, Singapore Med. J. 14: 68–81 (1973).Google Scholar
  185. 185.
    Shanmugaratnam, K., And Higginson, J., Aetiology of nasopharyngeal carcinoma: Report on a retrospective survey in Singapore, in: Cancer of the Nasopharynx (C. S. Muir And K. Shanmugaratnam, EDs.), pp. 130–137, Uicc Monograph Series, Vol. 1, Munksgaard, Copenhagen, 1967.Google Scholar
  186. 186.
    Shanmugaratnam, K., And Muir, C. S., Nasopharyngeal carcinoma: Origin and structure, in: Cancer of the Nasopharynx (C. S. Muir And K. Shanmugaratnam, Eds.), pp. 153–162, Uicc Monograph Series, Vol. 1, Munksgaard, Copenhagen, 1967.Google Scholar
  187. 187.
    Shanmugaratnam, K., And Tye, C. Y., A study of nasopharyngeal cancer among Singapore Chinese with special reference to migrant status and specific community (dialect group), J. Chron. Dis. 23: 433–441 (1970).PubMedCrossRefGoogle Scholar
  188. 188.
    Shanmugaratnam, K., Tye, C. Y., Goh, E. H., And Chia, K. B., Etiological factors in nasopharyngeal carcinoma: A hospital-based, retrospective case-control questionnaire study, in: Nasopharyngeal Carcinoma: Etiology and Control, (G. DE-THÉ And Y. Ito, EDs.), pp. 199–212, Iarc Scientific Publication No. 20, Iarc, Lyon, France, 1978.Google Scholar
  189. 189.
    Shanmugaratnam, K., And Wee, A., “Dialect group” variations in cancer incidence among Chinese in Singapore, in: Host Environment Interaction in the Etiology of Cancer in Humans (R. Doll And I. Bodopua, Eds.), pp. 67–82, Iarc Scientific Publication No. 7, Iarc, Lyon, France, 1973.Google Scholar
  190. 190.
    Shao, Y. M., Poirier, S., Ohshima, H., Malaveille, C., Zeng, Y., DE-THÉ, G., And Bartsch, H., Epstein-Barr virus activation in Raji cells by extracts of preserved food from high risk areas for nasopharyngeal carcinoma, Carcinogenesis 9: 1455–1457 (1988).PubMedCrossRefGoogle Scholar
  191. 191.
    Simons, M. J., Chan, S. H., Wee, G. B., Shanmugaratnam, K., Goh, E. H., Ho, J. L. C., Chau, J. C. W., Darmalingam, S., Prasad, U., Betuel, H., Day, N. E., And DE-THÉ, G., Nasopharyngeal carcinoma and histocompatibility antigens, in: Nasopharyngeal Carcinoma: Etiology and Control, (G. DE-THÉ And Y. Ito, Ens.), pp. 271–282, Iarc Scientific Publication No. 20, Iarc, Lyon, France, 1978.Google Scholar
  192. 192.
    Simons, M. J., Day, N. E., Wee, G. B., Chan, S. H., Shanmugaratnam, K., And DE-THÉ, G., Immunogenetic aspects of nasopharyngeal carcinoma (Npc). Iii. HL-A type as a genetic marker of Npc predisposition to test the hypothesis that Ebv is an aetiologic factor in Npc, in: Oncogenesis and Herpesviruses II (G. DE-THÉ, M. A. Epstein, And H. Zur Hausen, Eds.), pp. 249258, Iarc Scientific Publication No. 11, Vol. 2, Iarc, Lyon, France, 1975.Google Scholar
  193. 193.
    Simons, M. J., Day, N. E., Wee, G. B., Shanmugaratnam, K., Ho, H. C., Wong, S. H., TI, T. K., Yong, N. K., Darmalingam, S., And DE-THÉ, G., Nasopharyngeal carcinoma. V. Immunogenetic studies of South East Asian ethnic groups with high and low risk for the tumor, Cancer Res. 34: 1192–1195 (1974).PubMedGoogle Scholar
  194. 194.
    Simons, M. J., Wee, G. B., Day, N. E., Chan, S. H., Shanmugaratnam, K., And DE-THÉ, G., Immunogenetic aspects of nasopharyngeal carcinoma (Npc). IV. Probable identification of an HL-A second antigen associated with a high risk for Npc, Lancet 1: 142–143 (1975).PubMedCrossRefGoogle Scholar
  195. 195.
    Simons, M. J., Wee, G. B., Day, N. E., DE-THÉ, G., Morris, P. J., And Shanmugaratnam, K., Immunogenetic aspects of nasopharyngeal carcinoma. I. Differences in HL-A antigen profiles between patients and comparison groups, Int. J. Cancer 13: 122–134 (1974).PubMedCrossRefGoogle Scholar
  196. 196.
    Simons, M. J., Wee, G. B., Goh, E. H., Chan, S. H., Shanmugaratnam, K., Day, N. E., And DE-THÉ, G., Immunogenetic aspects of nasopharyngeal carcinoma, IV. Increased risk in Chinese of nasopharyngeal carcinoma associated with a Chinese-related Hla profile (A2, Singapore 2), J. Natl. Cancer Inst. 57: 977–980 (1976).PubMedGoogle Scholar
  197. 197.
    SIxBey, J. W., And Yao, Q. Y., Immunoglobulin A induced shift of Epstein-Barr virus tropism, Science 255: 1578–1580 (1991).CrossRefGoogle Scholar
  198. 198.
    Smith, G. E., And Dawson, W. R., Egyptian Mummies, p. 157, Allen and Unwin, London, 1924.Google Scholar
  199. 199.
    Sohier, R., And DE-THÉ, G., Fixation du complément avec un antigène soluble: Differences d’activité importantes entre les sérums de lymphoma de Burkitt, de cancer du rhinopharynx et de mononucléose infecteuse, C. R. Acad. Sci. ID] 273: 121–124 (1971).Google Scholar
  200. : Sohier, R., And DE-THÉ, G., Evolution of complement-fixing antibody titers with the development of Burkitt’s lymphoma, Int. J. Cancer 9: 524–528 (1972).CrossRefGoogle Scholar
  201. 201.
    Svoboda, D. J., Kirchner, K. R., And Shanmugaratnam, K., Ultrastructure of nasopharygeal carcinomas in American and Chinese patients: An application of electron microscopy to geographic pathology, Exp. Mol. Pathol. 4: 189–204 (1965).CrossRefGoogle Scholar
  202. 202.
    Svoboda, D. J., Kirchner, K. R., And Shanmugaratnam, K., The fine structure of nasopharyngeal carcinoma, in: Cancer of the Nasopharynx (C. S. Muir And K. Shanmugaratnam, Eds.), pp. 163–171, Uicc Monograph Series, Vol. 1, Munksgaard, Copenhagen, 1967.Google Scholar
  203. 203.
    Terracini, B., Magee, P. N., And Barnes, J. M., Hepatic pathology on low dietary levels of dimethylnitrosamine, Br. J. Cancer 21: 565–599 (1967).CrossRefGoogle Scholar
  204. 204.
    Trumper, P. A., Epstein, M. A., Giovanella, G. C., And Finerty, S., Isolation of infectious EB virus from epithelial tumor cells of nasopharyngeal carcinoma, Int. J. Cancer 20: 655–662 (1977).PubMedCrossRefGoogle Scholar
  205. 205.
    Union International Contre LE Cancer, Cancer Incidence in Five Continents-Technical Report (R. Doll, P. Payne, And J. Waterhouse, Eds.), Uicc, Geneva, 1966.Google Scholar
  206. 206.
    Union International Contre LE Cancer, Cancer Incidence in Five Continents, Vol. 2 ( R. Doll, C. Muir, And J. Water-House, Eds.), Uicc, Geneva, 1970.Google Scholar
  207. 207.
    Vonka, V., Benyesh-Melnick, M., Lewis, R. T., And Wimberly, I., Some properties of the soluble (S) antigen of cultured lymphoblastoid cell lines, Arch. Ges. Virusforsch. 31: 113–124 (1970).PubMedCrossRefGoogle Scholar
  208. 208.
    Vonka, V., Vlchova, I., Zavadova, H., Kouba, K., Lasovska, J., And Duben, J., Antibodies to EB virus capsid antigen and to soluble antigen of lymphoblastoid cell in infectious mononucleosis patients, Int. J. Cancer 9: 529–535 (1972).PubMedCrossRefGoogle Scholar
  209. 209.
    Vuillaume, M., And DE-THÉ, G., Nasopharyngeal carcinoma. II. Ultrastructure of different growths leading to lymphoblastoid transformation in vitro, J. Natl. Cancer Inst. 51: 67–80 (1973).Google Scholar
  210. 210.
    Walshe, R. J., The physical anthropology of races with a high incidence of nasopharyngeal cancer, in: Cancer of the Nasopharynx (C. S. Muir And K. Shanmugaratnam, Eds.), pp. 112–118, Uicc Monograph Series, Vol. 1, Munksgaard, Copenhagen, 1967.Google Scholar
  211. 211.
    Walters, M. K., And Pope, J. H., Studies of the EB virus-related antigens of human leukocyte cell lines, Int. J. Cancer 8: 32–40 (1971).PubMedCrossRefGoogle Scholar
  212. 212.
    Wara, W. M., Wara, D. W., Phillips, T. L., And Ammahh, A., Elevated IgA in carcinoma of the nasopharynx, Cancer 35: 1313–1315 (1975).PubMedCrossRefGoogle Scholar
  213. 213.
    Wells, C., Ancient Egyptian pathology, J. Laryngol. 77: 261–265 (1963).CrossRefGoogle Scholar
  214. 214.
    Wells, C., Two mediaeval cases of malignant disease, Br. Med. J. 1: 1611–1612 (1964).PubMedGoogle Scholar
  215. 215.
    Williams, E. H., And DE-THÉ, G., Familial aggregation in nasopharyngeal carcinoma (letter to the editor), Lancet 2: 295 (1974).PubMedCrossRefGoogle Scholar
  216. 216.
    Wolf, H., Zur Hausen, H., And Becker, V., EB viral genomes in epithelial nasopharyngeal carcinoma cells, Nature (New Biol.) 244: 245–257 (1973).Google Scholar
  217. 217.
    World Health Organization, Mortality from Malignant Neoplasms 1955–1965, Who, Geneva, 1970.Google Scholar
  218. 218.
    World Health Organization, Histological Typing of Upper Respiratory Tract Tumours: International Classification of Tumours, No. 19 ( K. Shanmugaratnam And L. H. Sobin, Eds.), Who, Geneva, 1978.Google Scholar
  219. 219.
    Worth, R. M., And Valentine, R., Nasopharyngeal carcinoma in New South Wales, Australia, in: Cancer of the Nasopharynx (C. S. Muir And K. Shanmugaratnam, Eds.), pp. 73–76, Uicc Monograph Series, Vol. 1, Munksgaard, Copenhagen, 1967.Google Scholar
  220. 220.
    Wu, C. H. (ED.), The Encyclopaedia of Chinese Medical Terms, Vol. 1, p. 756, Commercial Press, Shanghai, 1921 (in Chinese).Google Scholar
  221. 221.
    WU, T. C., Mann, R. B., Epstein, J. I., Macmahon, E., Lee, W. A., Charache, P., Hayward, S. D., Kurman, R. J., Hayward, G. S., And Ambinder, R. F., Abundant expression of Eber-1 small nuclear Rna in nasopharyngeal carcinoma. A morphological distinctive target for detection of Ebv in formalin fixed paraffin embedded specimen, Am. J. Pathol. 138: 1461–1469 (1991).PubMedGoogle Scholar
  222. 222.
    Yata, J., Desgranges, C., DE-THÉ, G., And Tachibana, T., Lymphocytes in infectious mononucleosis: Properties of the lymphoblastoid lines, Biomedicine 19: 479–484 (1973).PubMedGoogle Scholar
  223. 223.
    Yata, J., Desgranges, C., DE-THÉ, G., And Tachibana, T., Nasopharyngeal carcinoma. Vii. Lymphocyte subpopulations in the blood and tumour tissue, Biomedicine 21: 244–250 (1974).PubMedGoogle Scholar
  224. 224.
    Yata, J., Desgranges, C., Nakagawa, T., Favri, M. C., And DE-THÉ, G., Lymphoblastoid transformation and kinetics in the appearance of Epstein-Barr viral nuclear antigen (Ebna) in cord blood B cells by Epstein-Barr virus infection, Int. J. Cancer 15: 377–384 (1975).PubMedCrossRefGoogle Scholar
  225. 225.
    Yeh, S., Histology of nasopharyngeal cancer, in: Cancer of the Nasopharynr (C. S. Muir And K. Shanmugaratnam, Eds.), pp. 147–152, Uicc Monograph Series, Vol. 1, Munksgaard, Copenhagen, 1967.Google Scholar
  226. 226.
    Young, D., Sixbey, J. W., Clarck, D., And Rickinson, A. B., Epstein-Barr virus receptors on human pharyngeal epithelia, Lancet 1: 240–242 (1986).PubMedCrossRefGoogle Scholar
  227. 227.
    Yu, M. C., Ho, J. H. C., Lai, S. H., And Henderson, B. E., Cantonese style salted fish as a cause of nasopharyngeal carcinoma: Report of a case-control study in Hong Kong, Cancer Res. 46: 956–961 (1986).PubMedGoogle Scholar
  228. 228.
    Yun, I. S., A statistical study of tumors among Koreans, Cancer Res. 9: 370–371 (1949).PubMedGoogle Scholar
  229. 229.
    Zaouche, A., Les tumeurs malignes de la sphère Orl en Tunisie: A propos des 644 tumeurs des voies aerodigestives superieures à l’Institut National de Carcinologie de Tunis due 1.10.67 au 15.8.69, Thesis, Paris, 1970.Google Scholar
  230. 230.
    Zeng, Y., Seroepidemiological studies of nasopharyngeal carcinoma in China, Adv. Cancer Res. 44: 121–138 (1985).PubMedCrossRefGoogle Scholar
  231. 231.
    Zeng, Y., Hong, D., Jianming, Z., Naiqin, H., Pingjun, L., Wenjun, P., Yuying, H., Yue, L., Peizhong, W., And DE THÉ, G., A 10-year prospective study on nasopharyngeal carcinoma in Wuzhou city and Zangwu County, Guangxi, China, in: The Epstein-Barr virus and associated diseases: Proceedings of the Vth International Symposium (T. Tursz, J. S. Pagano, D. V. Ablashi, G. DE-THÉ, G. Lenoir, And G. R. Pearson, Eds.), pp. 735–742, Colloques Inserm/John Libbey Eurotext Publishing, Paris, 1993.Google Scholar
  232. 232.
    Zeng, Y., Gong, C. H., Jan, M. G., Fun, Z., Zhang, L. G., And LI, H. Y., Detection of Epstein-Barr virus IgA/EA antibody for diagnosis of nasopharyngeal carcinoma by immunoautoradiography, Int. J. Cancer 31: 599–601 (1983).PubMedCrossRefGoogle Scholar
  233. 233.
    Zeng, Y., Liu, Y. X., Liu, C. R., Chen, S. W., Wei, J. N., Zhu, J. N., And Zai, H. J., Application of immunoenzymatic method and immunoautoradiographic method for the mass survey of nasopharyngeal carcinoma, Intervirology 133: 166–168 (1980).Google Scholar
  234. 234.
    Zeng, Y., Oshima, H., Bouvier, G., Roy, P., Jianming, Z., LI, B., Brouet, I., DE-THÉ, G., And Bartsch, H., Urinary excretion of nitrosamino acids and nitrate by inhabitants of high-and low-risk areas for nasopharyngeal carcinoma in Southern China, Cancer Epidemiol. Biomarkers Prey. 2: 195–200 (1993).Google Scholar
  235. 235.
    Zeng, Y., Shang, M., Liu, C. R., Chen, S. W., Wei, J. N., Zhu, J. S., And Zai, H. G., Detection of anti-Epstein-Barr virus IgA in Npc patients in 8 provinces and cities in China, Chin. Oncol. 1: 27 (1979).Google Scholar
  236. 236.
    Zeng, Y., Shen, S., Gudhua, P., MA, J. L., Zhang, Q., Zhao, M. G., And Dong, H. J., Application of anticomplement immunoenzymatic method for the detection of Ebna in carcinoma cells and normal epithelial cells from the nasopharynx, in: Nasopharyngeal Carcinoma Cancer Campaign, Vol. 5 (E. Grundmann, G. R. F. Krueger, And D. V. Ablashi, Eds.), pp. 237–245, Gustav Fischer Verlag, Stuttgart, 1981.Google Scholar
  237. 237.
    Zeng, Y., Zhang, L. G., Li, H. Y., Jan, M. G., Zhang, Q., Wu, Y. C., Wang, Y. S., And Su, G. R., Serological mass survey for early detection of nasopharyngeal carcinoma in Wu-Zhou City, China, Int. J. Cancer 29: 139–141 (1982).PubMedCrossRefGoogle Scholar
  238. 238.
    Zeng, Y., Zhong, J. M., Li, L. Y., Wang, P. Z., Tang, H., MA, Y. R., Zhu, J. S., Pan, W. J., Lio, Y. X., Wei, Z. N., Chen, J. Y., Mo, Y. K., Li, E. J., And Tan, B. F., Follow-up studies on Epstein—Barr virus IgA/Vca antibody positive persons in Zangwu County, China, Intervirology 20: 190–194 (1983).PubMedCrossRefGoogle Scholar
  239. 239.
    Zur Hausen, H., Schulte-Holthausen, H., Klein, G., Henle, W., Henle, G., Clifford, P., And Santesson, L., Ebv Dna in biopsies of Burkitt tumours and anaplastic carcinomas of the nasopharynx, Nature 228: 1056–1058 (1970).PubMedCrossRefGoogle Scholar

Suggested Reading

  1. de-Thé, G., Epidemiology, pathogenesis and prevention of Ebv associated malignancies, in: The Epstein—Barr Virus and Associated Diseases. pp. 15–30, ( T. Tursz, J. Pagano, M. Ablashi, G. DE-THÉ, G. Lenoir, And G. Pearson, Eds.), Inserm and John Libbey Eurotext Publishing, Paris, 1993.Google Scholar
  2. de-Thé, G., Epidemiology of Epstein—Barr virus and associated diseases in man, in: Herpesviruses, Vol. 1 (B. Roizman, ED.), pp. 25–103, Plenum Press, New York, 1982.Google Scholar
  3. de-Thé, G., And Yto, Y. (Eds.), Nasopharyngeal Carcinoma: Etiology and Control, [Arc Scientific Publication No. 20, Iarc, Lyon, France, 1978.Google Scholar
  4. Gzundman, E., Kzueger, G., Zundman, E., Kzueger, G. R. F., And Ablashi, D. V. (Eds.), Nasopharyngeal Carcinoma Cancer Campaign, Vol. 5, Gustav Fischer Verlag, Stuttgart, 1981.Google Scholar
  5. Levine, P., Ablashi, D., And Pearson, G. (Eds.), Epstein—Barr Virus and Human Diseases, Humana Press, Clifton, NJ, 1987.Google Scholar
  6. Muir, C. S., Nasopharyngeal carcinoma in non-Chinese populations with special reference to South East Asia and Africa, Int. J. Cancer 8: 351–363 (1971).PubMedGoogle Scholar
  7. Muir, C. S., And Shanmugaratnam, K. (Eds.), Cancer of the Nasopharynx, Uicc Monograph Series, No. 1, Munksgaard, Copenhagen, 1967.Google Scholar

Copyright information

© Springer Science+Business Media New York 1997

Authors and Affiliations

  • G. de-Thé
    • 1
  1. 1.The Pasteur InstituteParisFrance

Personalised recommendations